Here are the currently confirmed sessions

  • BBB in brain tumors: compromised or maintained
  • Brain imaging
  • Cellular origins of childhood brain tumors
  • Clinical Outcome Assessments
  • Cognitive functioning
  • EANO-EAN Session: Neurotoxicity from antineoplastic treatments
  • EANO-EANM Session: New developments in imaging tracers and beyond
  • EANO-SNO Session
  • Exploring new radiation therapy technologies
  • Genome editing strategies for modelling brain tumors in mice
  • Image-guided Neurosurgery
  • Impact of tumor plasticity on experimental therapies
  • Influence of brain tumors on neuronal circuits
  • Lower grade IDH mutated glioma: treatment after surgery
  • Modeling disease in a dish and its potential for drug screens
  • Multilayer Diagnostics
  • Neurosurgical Precision Tools
  • Quality of life
  • Radiobiology
  • Rare Tumors: EURACAN
  • Rationalizing combination partners of immunotherapies
  • scRNAseq: new techniques and implications
  • Symptom management
  • Targeting aberrant DNA damage response phenotypes in glioma
  • Tumor Heterogeneity